Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Genetic polymorphism and cancer].

M Maekawa1

  • 1Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu 431-3192.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|April 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Saccades and prefrontal hemodynamics in basketball players.

International journal of sports medicine·2009
Same author

CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells.

Leukemia·2009
Same author

Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells.

Leukemia·2005
Same author

[Relationship between exposure to formaldehyde and symptoms of irritation during human-dissection course at Chiba University].

Kaibogaku zasshi. Journal of anatomy·2004
Same author

Development of the amygdalohypothalamic projection in the mouse embryonic forebrain.

Anatomy and embryology·2004
Same author

[The introduction of teaching assistant system by medical students during educational human dissection tour at Chiva University].

Kaibogaku zasshi. Journal of anatomy·2004
Same journal

[The Role of Laboratory Medicine in Hematopoietic Stem Cell Transplantation "Echocardiogram"].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[The Significance of Pulmonary Function Testing Before and After Allogeneic Stem Cell Transplantation].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[Blood Transfusion Inspection].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[The Role of Clinical Laboratory Technicians at Bone Marrow Transplantation : Blood Test].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[The Foundation of Allogeneic Hematopoietic Stem Cell Transplantation and the Role of Clinical Laboratory Tests in This Field].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[How to Interpret Data from Routine Laboratory Tests].

Rinsho byori. The Japanese journal of clinical pathology·2019
See all related articles

Genetic polymorphisms significantly impact cancer diagnosis, risk assessment, and treatment. Understanding these variations enables personalized cancer care, including tailored therapies and preventative strategies.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Epidemiology

Context:

  • Genetic variations, or polymorphisms, play a crucial role in cancer development and progression.
  • Clinical laboratory data, such as cancer antigen 19-9 (CA19-9) levels, can be influenced by specific genetic polymorphisms.
  • Molecular epidemiological studies highlight the link between genetic polymorphisms and cancer susceptibility, identifying potential biomarkers for risk assessment.

Purpose:

  • To review the clinical and pathological significance of genetic polymorphisms in cancer.
  • To explore the implications of genetic polymorphisms in cancer diagnosis, laboratory testing, susceptibility, and drug sensitivity.

Summary:

  • Genetic polymorphisms are relevant to cancer diagnosis, particularly in assessing loss of heterozygosity.

Related Experiment Videos

  • Variations in genes like secretor and Lewis can affect the accuracy of tumor marker levels (e.g., CA19-9).
  • Certain genetic polymorphisms are associated with increased cancer susceptibility, serving as biomarkers for cancer risk.
  • Individual differences in drug metabolism due to genetic polymorphisms influence drug toxicity and efficacy, guiding personalized drug selection.

    • Impact:

    • Genetic polymorphisms are integral to the clinical management of cancer.
    • Accumulating knowledge on genetic polymorphisms facilitates the development of personalized medicine, including tailored therapies, prevention strategies, and diagnostic approaches for individual patients.